nodes	percent_of_prediction	percent_of_DWPC	metapath
Phylloquinone—GGCX—uterine cervix—vaginal cancer	0.154	0.154	CbGeAlD
Phylloquinone—GGCX—endometrium—vaginal cancer	0.139	0.139	CbGeAlD
Phylloquinone—GGCX—mammalian vulva—vaginal cancer	0.135	0.135	CbGeAlD
Phylloquinone—GGCX—uterus—vaginal cancer	0.128	0.128	CbGeAlD
Phylloquinone—BGLAP—female reproductive system—vaginal cancer	0.118	0.118	CbGeAlD
Phylloquinone—GGCX—female reproductive system—vaginal cancer	0.115	0.115	CbGeAlD
Phylloquinone—GGCX—female gonad—vaginal cancer	0.105	0.105	CbGeAlD
Phylloquinone—GGCX—vagina—vaginal cancer	0.104	0.104	CbGeAlD
